VICTORIA CURTISS: Open Payments
NPI 1043799380 · PORTLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 17 payments from 6 companies in 2025. Trend: 2023 $373 · 2024 $449 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $138 |
| Amgen Inc. | 4 | $60 |
| Exact Sciences Corporation | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: Wegovy, OTEZLA, Rybelsus, Ozempic, The Cologuard Plus Collection Kit, Cologuard Collection Kit, ZORYVE, CAPLYTA.
Industry payments across TX — which companies pay providers there.
